French biotech brings candidate for Gaucher and Parkinson’s disease in-house under 2020 pact with Weizmann. Cellevolve, Seattle Children’s partner on cell therapies for CNS cancers.

A new draft guidance from the National Institute for Health and Care Excellence (NICE) recommends the NHS use fecal immunochemical tests (FITs), instead of guaiac-based tests, for detecting gastrointestinal bleeding associated with bowel cancer.

Menarini has extended its commercial alliance for Teijin Pharma's gout drug febuxostat to a further 26 mainly emerging markets, acquiring exclusive distribution and marketing rights in Central and South America, the Commonwealth of Independent States and Australia/New Zealand.

In 2011, Bristol-Myers Squibb stopped a five-year slide in Japan, turning sales into the black for the first time since 2005.